Log in to save to my catalogue

Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded h...

Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded h...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7225197

Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells

About this item

Full title

Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Histochemistry and cell biology, 2020-05, Vol.153 (5), p.367-377

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

A major limitation in the pharmacological treatment of clinically detectable primary cancers and their metastases is their limited accessibility to anti-cancer drugs (cytostatics, inhibitory antibodies, small-molecule inhibitors) critically impairing therapeutic efficacies. Investigations on the tissue distribution of such drugs are rare and have o...

Alternative Titles

Full title

Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7225197

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7225197

Other Identifiers

ISSN

0948-6143

E-ISSN

1432-119X

DOI

10.1007/s00418-020-01857-x

How to access this item